Clinical trials: Peripheral ICC
Intrahepatic Cholangiocarcinoma, Peripheral Cholangiocarcinoma
Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)
The purpose of this study is to use both, liver pump treatment and systemic chemotherapy, to assess the effects this type of treatment has on the patient and the tumor.
- Conditions
- Intrahepatic Cholangiocarcinoma, Peripheral Cholangiocarcinoma, Cholangiolar Carcinoma, Cholangiocellular Carcinoma
- Trial name
- NCT01862315
- Testing
- Floxuridine (FUDR), dexamethasone, Gemcitabine
- Where
- 6 sites in United States
- Volunteers
- 56 people
- Sponsor
- Memorial Sloan Kettering Cancer Center
Peripheral ICC
Vascular Positioning System G4 Algorithm ECG Data Collection for Model Training Study
The objective of this study is to collect intravascular and extravascular echocardiogram (ECG) data from subjects receiving peripherally inserted central catheters (PICC) while using the Vascular Positioning System G4 and a 12…
- Trial name
- NCT05702515
- Testing
- Digital ECG Data Collection
- Where
- United States
- Volunteers
- 27 people, healthy volunteers welcome
- Sponsor
- Teleflex
Peripheral ICC
PICC Asymptomatic Thrombosis Study: A Pilot Study
The study purpose is to perform a preliminary, comparative evaluation of the Hydrophilic Biomaterial technology to confirm the performance of the catheter, by using UltraSound technology in-vivo.
- Trial name
- NCT04920929
- Testing
- Hydrophilic Biomaterial, Thermoplastic Polyurethane
- Where
- United States
- Volunteers
- 7 people
- Sponsor
- Access Vascular Inc